AKERO THERAPEUTICS INC's ticker is and the CUSIP is 00973Y958. A total of 4 filers reported holding AKERO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $58,650 | -89.3% | 2,500 | -88.5% | 0.00% | -100.0% |
| Q1 2024 | $548,142 | -85.5% | 21,700 | -86.6% | 0.00% | -80.0% |
| Q4 2023 | $3,789,705 | -52.1% | 162,300 | +3.7% | 0.01% | -63.0% |
| Q3 2023 | $7,915,770 | +4.3% | 156,500 | -3.7% | 0.03% | +12.5% |
| Q2 2023 | $7,587,125 | +11565.0% | 162,500 | +9458.8% | 0.02% | – |
| Q1 2023 | $65,042 | -99.5% | 1,700 | -99.3% | 0.00% | -100.0% |
| Q4 2022 | $12,658,800 | +218.9% | 231,000 | +98.1% | 0.03% | +262.5% |
| Q3 2022 | $3,970,000 | +16441.7% | 116,600 | +4564.0% | 0.01% | – |
| Q2 2022 | $24,000 | -82.0% | 2,500 | -73.4% | 0.00% | – |
| Q1 2022 | $133,000 | -41.2% | 9,400 | +3.3% | 0.00% | – |
| Q2 2021 | $226,000 | -93.6% | 9,100 | -92.5% | 0.00% | -100.0% |
| Q1 2021 | $3,531,000 | +796.2% | 121,700 | +670.3% | 0.01% | +150.0% |
| Q2 2020 | $394,000 | +32.7% | 15,800 | +12.9% | 0.00% | 0.0% |
| Q1 2020 | $297,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 162,500 | $7,587,125 | 0.02% |
| JANE STREET GROUP, LLC | 359,500 | $16,785,055 | 0.01% |
| SIMPLEX TRADING, LLC | 54,700 | $2,553 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 11,100 | $518,259 | 0.00% |